Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-04-07FDA Approved: LEVETIRACETAM — Supplemental Application (SOHM, Inc.)
The FDA approved a supplemental application for levetiracetam by SOHM, Inc., adding to the existing regulatory approval for the product.
-
FDA approval · 2010-03-15FDA Approved: VALPROIC ACID — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved the supplemental application for Valproic Acid filed by PAI Holdings dba PAI Pharma.
-
FDA approval · 2010-02-26FDA Approved: ZONISAMIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for zonisamide from BluePoint Laboratories, signaling approval of changes to the generic product.
-
FDA approval · 2010-02-26FDA Approved: ZONISAMIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for zonisamide submitted by Aurobindo Pharma Limited. The approval confirms the changes requeste…
-
FDA approval · 2010-02-26FDA Approved: ZONISAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental application for zonisamide (generic) under ANDA077634. This action approves the sup…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-02-25FDA Approved: LEVETIRACETAM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for levetiracetam by Bionpharma Inc. under ANDA 079120. This approval marks the availability of a ge…
-
FDA approval · 2010-02-23FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the Supplemental Application for lamotrigine by Aurobindo Pharma Limited, resulting in approval of a generic lamotrigine produc…
-
FDA approval · 2010-02-23FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2010-02-23FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lamotrigine filed by Zydus Pharmaceuticals USA Inc., authorizing changes to the approved pro…
-
FDA approval · 2010-02-23FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for carbamazepine (generic).
-
FDA approval · 2010-02-23FDA Approved: TOPIRAMATE — Supplemental Application (Aurobindo Pharma Limited)
FDA supplemental approval for Topiramate by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: Early Surgical Intervention to Treat Epilepsy [Phase 3]
A Phase 3 trial sponsored by UCLA evaluated early surgical intervention for epilepsy, specifically temporal lobe epilepsy. The study status …
-
FDA approval · 2010-02-17FDA Approved: VALPROATE SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original ANDA for valproate sodium, a generic anticonvulsant.
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Thalidomide Low Threshold in Epilepsy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating thalidomide for refractory epilepsy has completed, with results posted in 2010. The study was sponsored …
-
CLINICAL_TRIALS research · 2010-01-28Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) As A Tool For Prospective Responder Identification Before Vagus Nerve Stimulation (VNS) Implantation [NA]
A clinical trial update from the University of Lübeck exploring whether transcranial direct current stimulation (tDCS) can identify prospect…
-
FDA approval · 2010-01-27FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a Supplemental Application for carbamazepine by Sun Pharmaceutical Industries, Inc. under an ANDA, marking an approved change t…
-
FDA approval · 2010-01-27FDA Approved: TOPIRAMATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Cipla USA Inc. to market a generic topiramate product.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Use of the Atkins Diet for Adults With Intractable Epilepsy [NA]
A completed clinical trial assessed the Atkins diet as a treatment option for adults with intractable epilepsy. The study was sponsored by J…
-
FDA approval · 2010-01-21FDA Approved: PHENYTOIN SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for phenytoin sodium from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2010-01-21FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lamotrigine Kit submitted by OWP Pharmaceuticals, Inc.
-
FDA approval · 2010-01-20FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for divalproex sodium submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2010-01-20FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for divalproex sodium. The approval covers the submitted supplemental chang…
-
FDA approval · 2010-01-20FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approves a supplemental application for divalproex sodium filed by Bionpharma Inc., resulting in an approved update under the ANDA proce…
-
FDA approval · 2010-01-20FDA Approved: CLORAZEPATE DIPOTASSIUM — Supplemental Application (NORTHSTAR RX LLC)
The FDA approved a supplemental application for clorazepate dipotassium submitted by Northstar RX LLC.
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets [Phase 1]
Phase 1 fasting bioequivalence study comparing Primidone tablets and Mysoline tablets to establish therapeutic equivalence.